Literature DB >> 22705994

Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.

N J Weston-Bell, D Hendriks, G Sugiyarto, N A Bos, H C Kluin-Nelemans, F Forconi, S S Sahota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22705994     DOI： 10.1038/leu.2012.163

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.

Authors:  Y Niu; X Yang; Y Chen; X Jin; Y Xie; Y Tang; L Li; S Liu; Y Guo; X Li; L Duan; H Wang
Journal:  Clin Transl Oncol       Date:  2019-01-29       Impact factor: 3.405

2.  Genome-wide promoter methylation of hairy cell leukemia.

Authors:  Alberto J Arribas; Andrea Rinaldi; Giorgia Chiodin; Ivo Kwee; Afua Adjeiwaa Mensah; Luciano Cascione; Davide Rossi; Meena Kanduri; Richard Rosenquist; Emanuele Zucca; Peter W Johnson; Gianluca Gaidano; Christopher C Oakes; Francesco Bertoni; Francesco Forconi
Journal:  Blood Adv       Date:  2019-02-12

3.  The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.

Authors:  Mariela Sivina; Robert J Kreitman; Evgeny Arons; Farhad Ravandi; Jan A Burger
Journal:  Br J Haematol       Date:  2014-04-02       Impact factor: 6.998

4.  Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.

Authors:  Nicola J Weston-Bell; Will Tapper; Jane Gibson; Dean Bryant; Yurany Moreno; Melford John; Sarah Ennis; Hanneke C Kluin-Nelemans; Andrew R Collins; Surinder S Sahota
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

5.  Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Authors:  Eleftheria Lakiotaki; Georgia Levidou; Maria K Angelopoulou; Christos Adamopoulos; Gerassimos Pangalis; George Rassidakis; Theodoros Vassilakopoulos; Gabriella Gainaru; Pagona Flevari; Sotirios Sachanas; Angelica A Saetta; Athanasia Sepsa; Maria Moschogiannis; Christina Kalpadakis; Nikolaos Tsesmetzis; Vassilios Milionis; Ilenia Chatziandreou; Irene Thymara; Panayiotis Panayiotidis; Maria Dimopoulou; Eleni Plata; Konstantinos Konstantopoulos; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 6.  Genomics of Hairy Cell Leukemia.

Authors:  Enrico Tiacci; Valentina Pettirossi; Gianluca Schiavoni; Brunangelo Falini
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

7.  BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.

Authors:  Valentina Pettirossi; Alessia Santi; Elisa Imperi; Guido Russo; Alessandra Pucciarini; Barbara Bigerna; Gianluca Schiavoni; Elisabetta Fortini; Ariele Spanhol-Rosseto; Paolo Sportoletti; Roberta Mannucci; Maria Paola Martelli; Ludger Klein-Hitpass; Brunangelo Falini; Enrico Tiacci
Journal:  Blood       Date:  2014-12-05       Impact factor: 22.113

8.  Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.

Authors:  Nicola J Weston-Bell; Francesco Forconi; Hanneke C Kluin-Nelemans; Surinder S Sahota
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

9.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

10.  Expression of the muscle-associated gene MYF6 in hairy cell leukemia.

Authors:  Evgeny Arons; Hong Zhou; Mark Sokolsky; Daniel Gorelik; Katherine Potocka; Sarah Davies; Erin Fykes; Katherine Still; Daniel C Edelman; Yonghong Wang; Paul S Meltzer; Mark Raffeld; Adrian Wiestner; Liqiang Xi; Hao-Wei Wang; Maryalice Stetler-Stevenson; Constance Yuan; Robert J Kreitman
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.